Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.
Michele F EisengaIlja M NoltePeter van der MeerStephan J L BakkerCarlo A J M GaillardPublished in: BMC nephrology (2018)
In this study, we have shown that of the traditionally used markers of iron status, reduced TSAT, especially TSAT<ā10%, is most strongly associated with the risk of adverse outcomes in CKD patients irrespective of serum ferritin level, suggesting that clinicians should focus more on TSAT rather than ferritin in this patient setting. Specific attention to iron levels below this cutoff seems warranted in CKD patients.